XNAS · CNTX
+0.71% · +$0.0042 · Vol 11.7M
Market closed · last close 4:00 PM ET · price as of 19:57:45 ET
Context Therapeutics Inc. Common Stock

Context Therapeutics Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.5998
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is CNTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for CNTX are being assembled.
About Context Therapeutics Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
15
Country
US

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.6000
Day high
$0.6500
Day low
$0.5601
Previous close
$0.5956
52W high
$1.47
-59.06% from high
52W low
$0.5601
4% of range
Market cap
$54.7M
EPS
$-0.3300
Shares out
91.9M
Volume
11.7M
VWAP
$0.5836
Price history computed in-house
1W
-10.22%
1M
-59.06%
SMA 50 $0.7285 · below
SMA 200 $0.7285 · below
52W position 4%
Veridion warehouse edge

Warehouse intelligence for CNTX.

Veridion Score
44
0: 941: 622: 143: 204: 805: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

CNTX insider activity

Context Therapeutics Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for CNTX.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

CNTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CNTX in this window.
Lobbying spend

CNTX lobbying filings, year to date.

Registered lobbying filings matched to Context Therapeutics Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CNTX in this window.
Latest news · CNTX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for CNTX.
Options
Sovereign unlock shows live options positioning for CNTX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.